End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.44 CNY | -1.32% | -1.92% | -15.73% |
2023 | Yiling Pharmaceutical Gets Nod for China Clinical Trial of Tracheobronchitis Drug | MT |
2023 | Yiling Pharmaceutical's Lianhua Qingke Tablets Gets Nod to Become Over-the-Counter Drug; Shares Up 4% | MT |
Business Summary
Number of employees: 15,074
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Respiratory System
54.8
%
| 4,108 | 40.6 % | 6,872 | 54.8 % | +67.29% |
Cardiovascular
33.3
%
| 4,534 | 44.8 % | 4,178 | 33.3 % | -7.87% |
Others
8.8
%
| 1,004 | 9.9 % | 1,101 | 8.8 % | +9.64% |
Other Patented Products
3.1
%
| 471 | 4.7 % | 383 | 3.1 % | -18.71% |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
96.3
%
| 9,760 | 96.5 % | 12,070 | 96.3 % | +23.67% |
Foreign
3.7
%
| 357 | 3.5 % | 463 | 3.7 % | +29.71% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xiang Jun Wu
CEO | Chief Executive Officer | 49 | 04-12-31 |
Chen Guang Li
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Qiu Lian Zhang
BRD | Director/Board Member | 54 | 15-03-15 |
Rui Wu
BRD | Director/Board Member | 44 | 10-08-30 |
Hua Wang
IRC | Investor Relations Contact | - | - |
Shao Hua Zhao
PRN | Corporate Officer/Principal | 58 | 94-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Ling Wu
FOU | Founder | 75 | 01-08-27 |
Xiang Jun Wu
CEO | Chief Executive Officer | 49 | 04-12-31 |
Xue Dong Gao
CHM | Chairman | 54 | 10-08-30 |
Rui Wu
BRD | Director/Board Member | 44 | 10-08-30 |
Wei Dong Xu
BRD | Director/Board Member | 56 | 20-01-15 |
Gen Wu Liu
BRD | Director/Board Member | 51 | 14-08-17 |
Zhen Wang
BRD | Director/Board Member | 51 | 16-12-11 |
Qiu Lian Zhang
BRD | Director/Board Member | 54 | 15-03-15 |
Xiao Han Liu
BRD | Director/Board Member | 69 | 20-01-15 |
Pei Yong Gao
BRD | Director/Board Member | 59 | 20-06-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,670,705,376 | 696,455,299 ( 41.69 %) | 0 | 41.69 % |
Company contact information
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
No. 238 Tianshan Avenue High-tech Industrial Dev Zone
050035, Shijiazhuang
+86 311 8590 1712
http://www.yiling.cnSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.73% | 4.55B | |
+40.29% | 6.02B | |
-9.40% | 3.13B | |
-1.60% | 3.07B | |
-1.23% | 2.57B | |
+34.89% | 1.82B | |
-11.37% | 1.63B | |
-5.02% | 1.57B | |
-13.21% | 1.54B | |
+25.23% | 1.31B |
- Stock Market
- Equities
- 002603 Stock
- Company Shijiazhuang Yiling Pharmaceutical Co., Ltd.